PAM
NTRP

Panagora Asset Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Panagora Asset Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,563
Closed -$77K – 2725
2019
Q2 		$77K Sell
9,563
-1,656
-15% -$11.1K ﹤0.01% 2021
2019
Q1 		$61K Buy
11,219
+4,366
+64% +$18.8K ﹤0.01% 2002
2018
Q4 		$24K Buy
+6,853
New +$41.5K ﹤0.01% 2186

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Panagora Asset Management's NTRP Position: Q3 2019 in Review

Panagora Asset Management sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 9,563 shares — an estimated $77K sold.

Panagora Asset Management first reported a position in NTRP in Q4 2018 and held it in 3 quarters. The position peaked at $77K in Q2 2019. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

  • Panagora Asset Management reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 9,563 Neurotrope, Inc. Common shares in Q3 2019, an estimated $77K.
  • Panagora Asset Management first reported a position in Neurotrope, Inc. Common in Q4 2018 and held it in 3 quarters.
  • Panagora Asset Management's Neurotrope, Inc. Common position peaked at $77K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.